---
title: UniCAR T-Cell Potency-A Matter of Affinity between Adaptor Molecules and Adaptor
  CAR T-Cells?
date: '2024-07-13'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39000348/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240713181721&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'Although Chimeric Antigen Receptor (CAR) T-cells have shown high efficacy
  in hematologic malignancies, they can cause severe to life-threatening side effects.
  To address these safety concerns, we have developed adaptor CAR platforms, like
  the UniCAR system. The redirection of UniCAR T-cells to target cells relies on a
  Target Module (TM), containing the E5B9 epitope and a tumor-specific binding moiety.
  Appropriate UniCAR-T activation thus involves two interactions: between the TM and
  the ...'
disable_comments: true
---
Although Chimeric Antigen Receptor (CAR) T-cells have shown high efficacy in hematologic malignancies, they can cause severe to life-threatening side effects. To address these safety concerns, we have developed adaptor CAR platforms, like the UniCAR system. The redirection of UniCAR T-cells to target cells relies on a Target Module (TM), containing the E5B9 epitope and a tumor-specific binding moiety. Appropriate UniCAR-T activation thus involves two interactions: between the TM and the ...